デジタル乳房トモシンセシス装置市場レポート：動向、予測、競合分析 (2031年まで)

世界のデジタル乳房トモシンセシス装置市場の将来は、病院や診断センター市場での機会で有望視されています。世界のデジタル乳房トモシンセシス装置市場は、2025年から2031年までのCAGRが14.2%で、2031年までに推定122億米ドルに達すると予想されます。この市場の主な促進要因は、高齢化人口の急増、デジタル乳房トモシンセシス装置の継続的な技術進歩、乳がん検診に対する意識の高まりです。

• Lucintelによると、製品種類別では、デジタル乳房トモシンセシス装置分野の技術開発により、予測期間中、装置が引き続き大きなセグメントを占めると予測しています。
• 最終用途別では、乳がん有病率の上昇と息切れ、痛み、吐き気を訴えるがん患者の病院志向の高まりにより、病院が引き続き最大セグメントとなります。
• 地域別では、乳がん罹患率の上昇と同地域の医療インフラの改善により、アジア太平洋が予測期間中に最も高い成長を遂げる見込みです。

デジタル乳房トモシンセシス装置市場の戦略的成長機会

デジタル乳房トモシンセシス装置市場は急速に進化しており、画像技術の進歩や乳がん発見の向上に対する需要の高まりにより、さまざまな用途で大きな成長機会をもたらしています。デジタル乳房トモシンセシスは、乳房組織の3Dビューを提供し、診断精度を高め、偽陽性を減少させます。アプリケーションの拡大、患者の転帰の改善、アクセシビリティの向上を目指したイノベーションにより、この技術がより臨床に組み込まれるようになり、戦略的な成長機会が生まれています。以下では、デジタル乳房トモシンセシス装置市場における5つの主な成長機会の概略を示し、これらのアプリケーションがどのように市場拡大を促進する態勢を整えているかにハイライトを当てます。

• 診断精度の向上：デジタル乳房トモシンセシス技術は、従来の2Dマンモグラフィと比較して診断精度が大幅に向上しています。乳房組織を3次元的に見ることができるため、重なり合った構造をよりよく区別し、小さい腫瘍や密な腫瘍を特定するのに役立ちます。技術の進歩に伴い、画像の解像度をさらに高め、高度なアルゴリズムを組み込んで早期乳がんの検出率を向上させる機会があります。この成長機会は、診断ツールの改善が患者の転帰に大きな影響を与える乳がん罹患率の高い地域に特に関連します。
• 人工知能（AI）との統合：デジタル乳房トモシンセシスシステムへのAIの統合は、画像解析と判読を強化することで大きな成長機会となります。AIアルゴリズムは、異常検出の自動化、緊急性に基づく症例の優先順位付け、意思決定支援の提供によって放射線科医を支援することができます。この統合は診断プロセスを迅速化するだけでなく、通常であれば見逃される可能性のある懸念領域を強調することで精度を向上させます。デジタル乳房トモシンセシスシステムにおけるAI機能の拡大は、早期発見と個別化された治療計画の大幅な進歩を促進すると予想されます。
• 新興市場への拡大：デジタル乳房トモシンセシス技術を新興市場に拡大する機会が増えており、そこでは医療投資の増加と乳がん検診に対する意識の高まりが需要を生み出しています。費用対効果の高いソリューションの提供や現地の医療提供者との提携など、これらの地域特有のニーズに合わせてデジタル乳房トモシンセシスシステムを調整することで、市場への参入と成長が促進されます。このような拡大は、十分なサービスを受けていない地域の乳がん発見率を向上させるために極めて重要であり、高度な診断技術へのアクセスを向上させることを目的とした世界の保健イニシアティブに沿ったものです。
• ハイブリッド画像システム：デジタル乳房トモシンセシスと超音波やMRIなどの他のモダリティを組み合わせたハイブリッド画像診断システムの開発は、大きな成長機会となります。これらの統合システムは、さまざまな画像技術の長所を組み合わせることで総合的な診断能力を提供します。例えば、ハイブリッドシステムは、乳房デジタルトモシンセシスから得られる詳細な解剖学的情報と超音波検査から得られる機能的洞察を同時に提供し、病変の特徴づけと診断精度を高めることができます。この動向は、乳がん検診に対するより総合的なアプローチをサポートし、患者の管理と転帰の改善につながります。
• 患者中心の機能の重視：乳房デジタル・トモシンセシス・システムの患者中心の機能に投資することで、患者の体験とコンプライアンスを向上させ、成長を促進することができます。最近のイノベーションには、よりソフトな圧迫パドル、自動ポジショニングシステム、検査中の不快感を最小限に抑えるユーザーフレンドリーなインターフェースなどがあります。患者の快適性を高めることは、定期的な検診を促し、マンモグラフィに伴う不安を軽減する上で極めて重要です。患者中心の設計が優先される中、市場で製品を差別化し、より良い患者体験を提供することに重点を置く医療施設にアピールする機会があります。

デジタル乳房トモシンセシス装置市場は、さまざまな用途で戦略的成長を遂げる位置にあります。診断精度の向上、AIの統合、新興国市場への進出、ハイブリッド画像処理システムの開発、患者中心の機能重視などの開発機会が、乳がん検診の将来を形成しています。こうした成長機会を活用することで、早期発見の進歩、患者の転帰の改善、デジタル乳房トモシンセシス技術の世界の普及が促進されます。

デジタル乳房トモシンセシス装置市場の促進要因・課題

デジタル乳房トモシンセシス装置市場は、技術的、経済的、規制的なさまざまな要因の影響を受けており、これらの要因が市場の成長を促進し、課題となっています。デジタル乳房トモシンセシス技術が進歩するにつれて、乳がん検出と診断精度の向上に対する主要な需要に対応するようになります。しかし、市場は高コスト、統合の問題、規制の複雑さなどのハードルにも直面しています。これらの促進要因と課題を理解することは、進化する乳房画像技術の展望を切り開こうとする利害関係者にとって極めて重要です。

デジタル乳房トモシンセシス装置市場を牽引する要因は以下の通りです：

• 技術の進歩：画像技術の進歩は、デジタル乳房トモシンセシス市場の成長を大きく促進します。画像解像度の向上、検出器技術の改善、高度な再構成アルゴリズムが、より正確で詳細な乳房画像診断に貢献しています。このような技術的改良により、高密度乳腺組織や小さな病変をよりよく可視化できるようになり、診断精度が向上しています。自動解析のためのAIの組み込みなど、画像処理技術の継続的な研究開発は、臨床現場におけるデジタル乳房トモシンセシスシステムの採用をさらに促進し、乳がんの早期発見率を向上させます。
• 早期発見に対する需要の増加：乳がん早期発見の重要性に対する意識の高まりは、デジタル乳房トモシンセシス装置市場の主な促進要因です。世界的に乳がんの罹患率が増加する中、より正確で信頼性の高い結果を提供する高度な診断ツールに対する需要が高まっています。デジタル乳房トモシンセシスは、偽陽性を減らし、重なり合う構造をよりよく区別することができるため、患者と医療提供者の両方にとって魅力的な選択肢となっています。このような早期かつ正確な検出に対する需要の高まりが、デジタル乳房トモシンセシスシステムの市場成長と採用を後押ししています。
• 政府と医療への取り組み：乳がん検診と早期発見を促進する政府の取り組みと医療政策が、デジタル乳房トモシンセシス市場を牽引しています。定期的なマンモグラフィ検診を支援し、先進診断技術への資金援助を行うプログラムは、デジタル乳房トモシンセシスシステムへのアクセスを拡大します。さらに、特定の患者グループに対してデジタル乳房トモシンセシスの使用を推奨または義務付けるイニシアチブは、市場の成長をさらに後押しします。このような政策は、乳房デジタル・トモシンセシス装置の採用を増加させるだけでなく、患者の転帰の改善や末期がん治療に関する医療コストの削減にも貢献します。
• 人工知能（AI）との統合：デジタル乳房トモシンセシス装置へのAIの統合は診断能力を高め、市場成長を促進します。AIアルゴリズムは自動画像解析を支援し、腫瘍検出の精度を高め、放射線科医の作業負担を軽減します。この技術的進歩は、より迅速で正確な診断をサポートし、より良い患者管理につながります。また、AIの導入は、意思決定支援や症例の優先順位付けを行うことで放射線科医不足にも対応し、医療施設におけるデジタル乳房トモシンセシス装置の導入増加の重要な促進要因となっています。
• 患者の快適性と体験の重視：患者の快適性と体感の向上が、先進的なデジタル乳房トモシンセシス装置の採用を後押ししています。よりソフトな圧迫パドル、自動ポジショニング、ユーザーフレンドリーなインターフェースなどの技術革新は、スクリーニング中の患者の不快感や不安を軽減します。患者体験の向上は、推奨される検診の遵守率の向上と全体的な満足度の向上につながります。患者の懸念に対処し、プロセスをより快適にすることで、市場参入企業と医療企業は、より多くの女性に定期的な乳がん検診への参加を促すことができ、それによって市場の成長を促進することができます。

デジタル乳房トモシンセシス装置市場の課題は以下のとおりです：

• 装置コストの高さ：デジタル乳房トモシンセシス装置の高価格は、市場成長にとって依然として大きな課題です。高度な画像処理技術や洗練された機能がデジタル乳房トモシンセシス装置の高価格の一因となっており、特に小規模医療施設や新興市場では導入の障壁となる可能性があります。デジタル乳房トモシンセシス装置の購入と維持に多額の投資が必要なため、アクセスが制限され、こうした先進的なシステムの普及が遅れる可能性があります。この課題を克服するためには、コストの問題に対処し、より費用対効果の高いソリューションを開発することが重要です。
• 既存システムとの統合：デジタル乳房トモシンセシスシステムを既存の画像診断インフラや電子カルテ（EHR）と統合することは複雑で困難な課題です。新しいデジタル乳房トモシンセシス技術と従来のシステムとの間の互換性の問題は、ソフトウェアやハードウェアのアップグレードに追加投資が必要になる場合があります。円滑なワークフローと正確なデータ共有を確保するためには、効果的な統合が不可欠です。このような統合の課題を克服するには、多様な医療環境におけるデジタル乳房トモシンセシスシステムのシームレスな導入と利用を促進するための技術的および運用上のハードルに対処する必要があります。
• 規制とコンプライアンスの問題：デジタル乳房トモシンセシス市場において、規制要件とコンプライアンス問題の解決は重要な課題です。国によって医療機器に関する規制が異なるため、デジタル乳房トモシンセシスシステムの承認や販売に影響を及ぼす可能性があります。乳房デジタル・トモシンセシス装置が安全性、有効性、性能に関する厳格な基準を満たしていることを確認することは非常に重要ですが、時間とコストがかかる可能性があります。製造業者は規制の変化に常に対応し、規制当局と緊密に協力して承認プロセスを合理化し、市場参入を促進しなければなりません。

デジタル乳房トモシンセシス装置市場は、技術の進歩、早期発見に対する需要の増加、政府の支援策、AIの統合、患者の快適性の重視などの影響を受けています。しかし、高額な装置コスト、統合の問題、規制上のハードルなどの課題への対処が必要です。利害関係者が市場を効果的にナビゲートし、潜在的な障害を克服しながら成長の機会を活用するためには、これらの促進要因・課題を理解することが不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 世界のデジタル乳房トモシンセシス装置市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界のデジタル乳房トモシンセシス装置市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界のデジタル乳房トモシンセシス装置市場：製品種類別
  • 装置
  • アップグレード
• 世界のデジタル乳房トモシンセシス装置市場：最終用途別
  • 病院
  • 診断センター
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界のデジタル乳房トモシンセシス装置市場：地域別
• 北米のデジタル乳房トモシンセシス装置市場
• 欧州のデジタル乳房トモシンセシス装置市場
• アジア太平洋のデジタル乳房トモシンセシス装置市場
• その他地域のデジタル乳房トモシンセシス装置市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のデジタル乳房トモシンセシス装置市場の成長機会：製品種類別
  • 世界のデジタル乳房トモシンセシス装置市場の成長機会：最終用途別
  • 世界のデジタル乳房トモシンセシス装置市場の成長機会：地域別
• 世界のデジタル乳房トモシンセシス装置市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のデジタル乳房トモシンセシス装置市場の生産能力拡大
  • 世界のデジタル乳房トモシンセシス装置市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Hologic
• GE Healthcare
• Siemens Healthineers
• Dexela
• Fujifilm
• Planmed OY
• Trivitron Healthcare

The future of the global digital breast tomosynthesis equipment market looks promising with opportunities in the hospital, and diagnostic center markets. The global digital breast tomosynthesis equipment market is expected to reach an estimated $12.2 billion by 2031 with a CAGR of 14.2% from 2025 to 2031. The major drivers for this market are the surging aging population, ongoing technological advancement digital breast tomosynthesis equipment, and rising awareness about breast cancer screening.

• Lucintel forecasts that, within the product type category, equipment will remain a larger segment over the forecast period due to technological developments in the field of digital breast tomosynthesis equipment.
• Within the end use category, hospitals will remain the largest segment due to the rising prevalence of breast cancer and the increasing preference of cancer patients towards hospitals who are undergoing shortness of breath, pain, and nausea.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to growing breast cancer incidence and improvements in the healthcare infrastructure in the region.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Digital Breast Tomosynthesis Equipment Market

The digital breast tomosynthesis equipment market is evolving rapidly, driven by technological advancements and increasing demand for improved breast cancer screening and diagnosis. DBT, or 3D mammography, enhances the accuracy of breast imaging by providing a detailed, three-dimensional view of breast tissue, which helps in early detection and reducing false positives. As technology progresses, several emerging trends are shaping the market, including advancements in image quality, integration with artificial intelligence, and expanding applications. These trends reflect the ongoing innovation and growth within the digital breast tomosynthesis sector, addressing clinical needs and improving patient outcomes.

• Integration of Artificial Intelligence: The integration of AI into digital breast tomosynthesis systems is a significant trend, enhancing image analysis and diagnostic accuracy. AI algorithms assist radiologists by automatically identifying potential abnormalities, reducing reading time, and improving detection rates. Recent developments include AI tools that aid in distinguishing between benign and malignant lesions, offering decision support and reducing the likelihood of false positives. This technology also helps in prioritizing cases based on urgency, thereby streamlining workflow and enhancing overall efficiency in breast cancer screening.
• Advancements in Image Resolution and Quality: Technological advancements are leading to improvements in image resolution and quality for digital breast tomosynthesis systems. Newer models feature higher spatial resolution and contrast, allowing for clearer and more detailed images of breast tissue. This enhancement helps in better visualization of small or dense tumors and reduces the likelihood of missed diagnoses. Innovations include advanced detector technologies and optimized reconstruction algorithms, which contribute to more precise imaging and improved diagnostic confidence for radiologists.
• Hybrid Imaging Systems: The development of hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound or MRI, is gaining traction. These systems provide comprehensive breast imaging solutions by integrating complementary diagnostic technologies. Hybrid systems offer the advantage of combining detailed 3D imaging with additional functional or structural information, improving overall diagnostic accuracy and enabling better treatment planning. This trend reflects a shift towards more holistic approaches in breast cancer diagnosis and management.
• Increased Focus on Patient Comfort: Enhancements aimed at increasing patient comfort during digital breast tomosynthesis procedures are becoming a key trend. Newer digital breast tomosynthesis systems are designed to minimize discomfort and reduce examination time, addressing common patient concerns. Innovations include softer compression paddles, automated positioning systems, and improved ergonomics to enhance the patient experience. These advancements aim to encourage higher patient compliance with screening recommendations and make the diagnostic process less invasive and more patient-friendly.
• Expansion into Emerging Markets: The digital breast tomosynthesis market is expanding into emerging markets with increasing investments and installations in regions such as Asia-Pacific and Latin America. Efforts are focused on making digital breast tomosynthesis technology more accessible and affordable in these regions, where there is a growing demand for advanced breast imaging solutions. Partnerships with local distributors and healthcare providers, along with tailored product offerings, are helping to address the needs of these emerging markets and improve breast cancer detection rates globally.

The digital breast tomosynthesis equipment market is experiencing dynamic changes driven by technological innovations and a growing emphasis on improving breast cancer diagnosis. Emerging trends such as AI integration, enhanced image quality, hybrid imaging systems, patient comfort improvements, and market expansion into emerging regions are shaping the future of digital breast tomosynthesis. These developments are enhancing diagnostic accuracy, patient experience, and accessibility, reflecting a broader commitment to advancing breast cancer care and early detection.

Recent Developments in the Digital Breast Tomosynthesis Equipment Market

Recent developments in the digital breast tomosynthesis equipment market reflect a period of rapid innovation and improvement. As digital breast tomosynthesis continues to gain prominence in breast cancer screening and diagnosis, advancements are emerging that enhance imaging capabilities, patient experience, and integration with other technologies. These developments are driven by ongoing research, technological advancements, and a heightened focus on improving diagnostic accuracy and accessibility. The following outlines five key recent developments in the digital breast tomosynthesis equipment market.

• Enhanced Image Resolution and Quality: New digital breast tomosynthesis systems are incorporating advanced detector technologies and imaging algorithms to significantly improve image resolution and quality. Innovations such as higher spatial resolution detectors and optimized reconstruction techniques enable clearer, more detailed images of breast tissue. These advancements help in better visualizing small or dense tumors, thus improving diagnostic accuracy and reducing the rate of false positives. Enhanced image quality supports radiologists in making more precise assessments and helps in the early detection of breast cancer.
• Integration of Artificial Intelligence (AI): AI integration in digital breast tomosynthesis systems is becoming increasingly prevalent, offering tools that assist in automated image analysis and interpretation. AI algorithms are designed to detect abnormalities, prioritize cases, and provide decision support, reducing the workload on radiologists and enhancing diagnostic efficiency. These systems can help identify subtle lesions that may be missed by the human eye and offer predictive analytics based on large datasets, contributing to improved early detection and treatment planning.
• Development of Hybrid Imaging Systems: Hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound or MRI, are emerging as a significant trend. These systems provide a more comprehensive approach to breast imaging by integrating the strengths of multiple diagnostic technologies. For example, combining digital breast tomosynthesis with ultrasound can enhance lesion characterization and provide additional functional information. This integrated approach improves overall diagnostic accuracy and supports better clinical decision-making.
• Advancements in Patient Comfort: Recent digital breast tomosynthesis systems are designed with a greater focus on patient comfort. Innovations include softer compression paddles, automated positioning systems, and user-friendly interfaces that reduce discomfort and anxiety during the examination. These advancements aim to make the screening process less invasive and more pleasant for patients, which can lead to higher screening compliance and better patient experiences. Enhanced comfort features are particularly important in encouraging regular mammography screenings.
• Expansion and Accessibility in Emerging Markets: The digital breast tomosynthesis equipment market is expanding into emerging markets, driven by increased investments and efforts to make advanced breast imaging more accessible globally. Companies are working to adapt digital breast tomosynthesis technology to the specific needs and conditions of these regions, including cost-effective solutions and local partnerships. This expansion aims to improve breast cancer detection rates in areas with growing healthcare infrastructure and increasing awareness of the benefits of early screening.

Recent developments in the digital breast tomosynthesis equipment market highlight significant advancements in imaging technology, AI integration, patient comfort, and global accessibility. These improvements are transforming breast cancer screening and diagnosis, enhancing both the accuracy of detection and the overall patient experience. As technology continues to evolve, the digital breast tomosynthesis market is poised to offer even more sophisticated solutions for early breast cancer detection and effective clinical management.

Strategic Growth Opportunities for Digital Breast Tomosynthesis Equipment Market

The digital breast tomosynthesis equipment market is evolving rapidly, offering significant growth opportunities across various applications due to advancements in imaging technology and increasing demand for improved breast cancer detection. Digital breast tomosynthesis provides a 3D view of breast tissue, enhancing diagnostic accuracy and reducing false positives. Strategic growth opportunities are emerging as the technology becomes more integrated into clinical practice, with innovations aimed at expanding applications, improving patient outcomes, and increasing accessibility. The following outlines five key growth opportunities within the digital breast tomosynthesis equipment market, highlighting how these applications are poised to drive market expansion.

• Enhanced Diagnostic Accuracy: digital breast tomosynthesis technology offers significant improvements in diagnostic accuracy compared to traditional 2D mammography. The ability to view breast tissue in three dimensions helps in better distinguishing between overlapping structures and identifying small or dense tumors. As technology advances, there are opportunities to further enhance image resolution and incorporate advanced algorithms to improve detection rates for early-stage breast cancer. This growth opportunity is particularly relevant in regions with high breast cancer incidence, where improved diagnostic tools can significantly impact patient outcomes.
• Integration with Artificial Intelligence (AI): The integration of AI into digital breast tomosynthesis systems represents a major growth opportunity by enhancing image analysis and interpretation. AI algorithms can assist radiologists by automating the detection of abnormalities, prioritizing cases based on urgency, and providing decision support. This integration not only speeds up the diagnostic process but also improves accuracy by highlighting areas of concern that might otherwise be missed. The expansion of AI capabilities in digital breast tomosynthesis systems is expected to drive significant advancements in early detection and personalized treatment plans.
• Expansion into Emerging Markets: There is a growing opportunity to expand digital breast tomosynthesis technology into emerging markets, where increasing healthcare investments and rising awareness about breast cancer screening are creating demand. Tailoring digital breast tomosynthesis systems to meet the specific needs of these regions, such as offering cost-effective solutions and partnering with local healthcare providers, can facilitate market entry and growth. This expansion is crucial for improving breast cancer detection rates in underserved areas and aligns with global health initiatives aimed at increasing access to advanced diagnostic technologies.
• Hybrid Imaging Systems: Developing hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound or MRI, presents a significant growth opportunity. These integrated systems offer comprehensive diagnostic capabilities by combining the strengths of various imaging technologies. For instance, a hybrid system can provide detailed anatomical information from digital breast tomosynthesis alongside functional insights from ultrasound, enhancing lesion characterization and diagnostic accuracy. This trend supports a more holistic approach to breast cancer screening and can lead to better patient management and outcomes.
• Focus on Patient-Centric Features: Investing in patient-centric features in digital breast tomosynthesis systems can drive growth by improving patient experience and compliance. Recent innovations include softer compression paddles, automated positioning systems, and user-friendly interfaces that minimize discomfort during exams. Enhancing patient comfort is crucial for encouraging regular screenings and reducing anxiety associated with mammography. As patient-centric designs become a priority, there is an opportunity to differentiate products in the market and appeal to healthcare facilities focused on providing a better patient experience.

The digital breast tomosynthesis equipment market is positioned for strategic growth across various applications. Opportunities to enhance diagnostic accuracy, integrate AI, expand into emerging markets, develop hybrid imaging systems, and focus on patient-centric features are shaping the future of breast cancer screening. Leveraging these growth opportunities can drive advancements in early detection, improve patient outcomes, and broaden the reach of digital breast tomosynthesis technology globally.

Digital Breast Tomosynthesis Equipment Market Driver and Challenges

The digital breast tomosynthesis equipment market is influenced by a range of technological, economic, and regulatory factors that drive its growth and present challenges. As digital breast tomosynthesis technology advances, it addresses key demands for improved breast cancer detection and diagnostic accuracy. However, the market also faces hurdles such as high costs, integration issues, and regulatory complexities. Understanding these drivers and challenges is crucial for stakeholders aiming to navigate the evolving landscape of breast imaging technology.

The factors responsible for driving the digital breast tomosynthesis equipment market include:

• Technological Advancements: Advances in imaging technology significantly drive the growth of the digital breast tomosynthesis market. Enhanced image resolution, improved detector technologies, and sophisticated reconstruction algorithms contribute to more accurate and detailed breast imaging. These technological improvements enable better visualization of dense breast tissue and small lesions, thereby enhancing diagnostic accuracy. Continuous research and development in imaging techniques, such as incorporating AI for automated analysis, further drive the adoption of digital breast tomosynthesis systems in clinical settings, improving early detection rates of breast cancer.
• Increased Demand for Early Detection: Growing awareness about the importance of early breast cancer detection is a major driver for the digital breast tomosynthesis equipment market. With increasing incidences of breast cancer globally, there is a rising demand for advanced diagnostic tools that provide more precise and reliable results. Digital breast tomosynthesis capability to reduce false positives and better differentiate between overlapping structures makes it an attractive option for both patients and healthcare providers. This heightened demand for early and accurate detection propels the market growth and adoption of digital breast tomosynthesis systems.
• Government and Healthcare Initiatives: Government initiatives and healthcare policies promoting breast cancer screening and early detection drive the digital breast tomosynthesis market. Programs that support regular mammography screenings and help funding for advanced diagnostic technologies expand access to digital breast tomosynthesis systems. Additionally, initiatives that recommend or mandate the use of digital breast tomosynthesis for specific patient groups further boost market growth. Such policies not only increase the adoption of digital breast tomosynthesis equipment but also contribute to improved patient outcomes and reduced healthcare costs related to late-stage cancer treatment.
• Integration with Artificial Intelligence (AI): The integration of AI in digital breast tomosynthesis systems enhances diagnostic capabilities and drives market growth. AI algorithms assist in automated image analysis, improving the accuracy of tumor detection and reducing radiologists' workload. This technological advancement supports faster and more accurate diagnoses, leading to better patient management. The incorporation of AI also addresses the shortage of radiologists by providing decision support and prioritizing cases, making it a significant driver for the increased adoption of digital breast tomosynthesis equipment in medical facilities.
• Focus on Patient Comfort and Experience: Enhancements in patient comfort and experience are driving the adoption of advanced digital breast tomosynthesis systems. Innovations such as softer compression paddles, automated positioning, and user-friendly interfaces reduce patient discomfort and anxiety during screenings. Improved patient experience leads to higher compliance with recommended screenings and better overall satisfaction. By addressing patient concerns and making the process more comfortable, manufacturers and healthcare providers can encourage more women to participate in regular breast cancer screenings, thereby driving market growth.

Challenges in the digital breast tomosynthesis equipment market are:

• High Cost of Equipment: The high cost of digital breast tomosynthesis equipment remains a significant challenge for market growth. Advanced imaging technologies and sophisticated features contribute to the high price of digital breast tomosynthesis systems, which can be a barrier to adoption, particularly in smaller healthcare facilities or emerging markets. The substantial investment required for purchasing and maintaining digital breast tomosynthesis equipment may limit access and slow down the widespread adoption of these advanced systems. Addressing cost concerns and developing more cost-effective solutions are crucial for overcoming this challenge.
• Integration with Existing Systems: Integrating digital breast tomosynthesis systems with existing imaging infrastructure and electronic health records (EHR) can be complex and challenging. Compatibility issues between new digital breast tomosynthesis technologies and legacy systems may require additional investments in software and hardware upgrades. Effective integration is essential for ensuring smooth workflows and accurate data sharing. Overcoming these integration challenges involves addressing technical and operational hurdles to facilitate the seamless adoption and utilization of digital breast tomosynthesis systems in diverse healthcare settings.
• Regulatory and Compliance Issues: Navigating regulatory requirements and compliance issues is a significant challenge in the digital breast tomosynthesis market. Different countries have varying regulations regarding medical devices, which can impact the approval and marketing of digital breast tomosynthesis systems. Ensuring that digital breast tomosynthesis equipment meets rigorous standards for safety, effectiveness, and performance is critical but can be time-consuming and costly. Manufacturers must stay updated with regulatory changes and work closely with regulatory bodies to streamline the approval process and facilitate market entry.

The digital breast tomosynthesis equipment market is influenced by technological advancements, increasing demand for early detection, supportive government initiatives, AI integration, and a focus on patient comfort. However, challenges such as high equipment costs, integration issues, and regulatory hurdles need to be addressed. Understanding these drivers and challenges is essential for stakeholders to navigate the market effectively and leverage opportunities for growth while overcoming potential obstacles.

List of Digital Breast Tomosynthesis Equipment Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, digital breast tomosynthesis equipment companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital breast tomosynthesis equipment companies profiled in this report include-

• Hologic
• GE Healthcare
• Siemens Healthineers
• Dexela
• Fujifilm
• Planmed OY
• Trivitron Healthcare

Digital Breast Tomosynthesis Equipment by Segment

The study includes a forecast for the global digital breast tomosynthesis equipment market by product type, end use, and region.

Digital Breast Tomosynthesis Equipment Market by Product Type [Analysis by Value from 2019 to 2031]:

• Equipment
• Upgradation

Digital Breast Tomosynthesis Equipment Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Diagnostic Centers
• Others

Digital Breast Tomosynthesis Equipment Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Digital Breast Tomosynthesis Equipment Market

Recent developments in the digital breast tomosynthesis equipment market reflect advancements in technology and increasing adoption across various regions. Digital breast tomosynthesis, an advanced form of 3D mammography, is enhancing early breast cancer detection and diagnostic accuracy. As technology evolves, the market is experiencing significant growth driven by innovations in imaging technology, regulatory approvals, and shifts in clinical practice. Key developments in the United States, China, Germany, India, and Japan highlight these trends and demonstrate how different countries are advancing in the adoption and implementation of DBT technologies.

• United States: In the United States, recent developments in the digital breast tomosynthesis market include the introduction of more advanced digital breast tomosynthesis systems with higher resolution and faster imaging capabilities. Major players, such as Hologic and Siemens Healthineers, have launched new digital breast tomosynthesis models featuring improved contrast and reduced radiation doses. Enhanced artificial intelligence (AI) integration is also a notable trend, offering better image analysis and aiding in early cancer detection. The adoption of digital breast tomosynthesis is growing rapidly in both private and public healthcare settings, supported by favorable reimbursement policies and increasing awareness of its benefits in breast cancer screening and diagnosis.
• China: China is seeing significant progress in the digital breast tomosynthesis market with an increase in domestic production and adoption of digital breast tomosynthesis technology. Chinese companies are developing cost-effective digital breast tomosynthesis systems to meet the needs of the expanding healthcare sector. Recent developments include partnerships between local firms and international technology providers to enhance the quality and affordability of digital breast tomosynthesis equipment. Additionally, there has been a push for upgrading existing mammography units to incorporate digital breast tomosynthesis capabilities. The growing focus on early breast cancer detection, coupled with government support for advanced medical technologies, is driving the market expansion in China.
• Germany: Germany has made notable strides in the digital breast tomosynthesis market with advancements in both technology and clinical application. Recent developments include the introduction of digital breast tomosynthesis systems that offer improved image quality and more efficient workflow integration for radiologists. German hospitals and research institutions are increasingly adopting digital breast tomosynthesis technology to enhance diagnostic accuracy and patient outcomes. The country is also witnessing innovations in hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound, for comprehensive breast imaging. Supportive regulatory frameworks and investment in healthcare infrastructure are contributing to the growth and adoption of digital breast tomosynthesis equipment in Germany.
• India: In India, the digital breast tomosynthesis market is expanding as more healthcare facilities invest in advanced imaging technologies. Recent developments include the entry of new players offering affordable digital breast tomosynthesis systems tailored to the Indian market. The Indian government and private sector are increasingly recognizing the importance of early breast cancer detection, leading to increased installations of digital breast tomosynthesis equipment across various regions. There is also a growing focus on training healthcare professionals to effectively utilize digital breast tomosynthesis technology. Despite challenges such as cost and infrastructure limitations, the market is poised for growth driven by increasing awareness and demand for advanced diagnostic tools.
• Japan: Japan is experiencing significant developments in the digital breast tomosynthesis market, driven by technological advancements and high healthcare standards. Recent progress includes the introduction of digital breast tomosynthesis systems with enhanced imaging capabilities and integration with digital health records for improved patient management. Japanese companies are focusing on innovation and precision, developing digital breast tomosynthesis equipment that supports early breast cancer detection with minimal discomfort for patients. The adoption of digital breast tomosynthesis is supported by strong regulatory frameworks and a high level of investment in medical technology. Japan's emphasis on advanced imaging solutions and early diagnosis is fostering the growth of the digital breast tomosynthesis market.

Features of the Global Digital Breast Tomosynthesis Equipment Market

Market Size Estimates: Digital breast tomosynthesis equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Digital breast tomosynthesis equipment market size by product type, end use, and region in terms of value ($B).

Regional Analysis: Digital breast tomosynthesis equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, end uses, and regions for the digital breast tomosynthesis equipment market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the digital breast tomosynthesis equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the digital breast tomosynthesis equipment market by product type (equipment and upgradation), end use (hospitals, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Digital Breast Tomosynthesis Equipment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Digital Breast Tomosynthesis Equipment Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Digital Breast Tomosynthesis Equipment Market by Product Type
  • 3.3.1: Equipment
  • 3.3.2: Upgradation
• 3.4: Global Digital Breast Tomosynthesis Equipment Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Diagnostic Centers
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Digital Breast Tomosynthesis Equipment Market by Region
• 4.2: North American Digital Breast Tomosynthesis Equipment Market
  • 4.2.1: North American Market by Product Type: Equipment and Upgradation
  • 4.2.2: North American Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.3: European Digital Breast Tomosynthesis Equipment Market
  • 4.3.1: European Market by Product Type: Equipment and Upgradation
  • 4.3.2: European Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.4: APAC Digital Breast Tomosynthesis Equipment Market
  • 4.4.1: APAC Market by Product Type: Equipment and Upgradation
  • 4.4.2: APAC Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.5: ROW Digital Breast Tomosynthesis Equipment Market
  • 4.5.1: ROW Market by Product Type: Equipment and Upgradation
  • 4.5.2: ROW Market by End Use: Hospitals, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Digital Breast Tomosynthesis Equipment Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Digital Breast Tomosynthesis Equipment Market by End Use
  • 6.1.3: Growth Opportunities for the Global Digital Breast Tomosynthesis Equipment Market by Region
• 6.2: Emerging Trends in the Global Digital Breast Tomosynthesis Equipment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Digital Breast Tomosynthesis Equipment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Breast Tomosynthesis Equipment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hologic
• 7.2: GE Healthcare
• 7.3: Siemens Healthineers
• 7.4: Dexela
• 7.5: Fujifilm
• 7.6: Planmed OY
• 7.7: Trivitron Healthcare